Application 050625

Type
NDA
Sponsor
NOVARTIS

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001SANDIMMUNECYCLOSPORINECAPSULE;ORAL25MGYesNo
002SANDIMMUNECYCLOSPORINECAPSULE;ORAL100MGYesYes
003SANDIMMUNECYCLOSPORINECAPSULE;ORAL50MGYesNo

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
0078-0240SandimmunecyclosporineNovartis Pharmaceuticals CorporationNDACurrent
0078-0240SandimmunecyclosporineNovartis Pharmaceuticals CorporationNDACurrent
0078-0240SandimmunecyclosporineNovartis Pharmaceuticals CorporationNDACurrent
0078-0240SandimmunecyclosporineNovartis Pharmaceuticals CorporationNDACurrent
0078-0240SandimmunecyclosporineNovartis Pharmaceuticals CorporationNDACurrent
0078-0240SandimmunecyclosporineNovartis Pharmaceuticals CorporationNDACurrent
0078-0241SandimmunecyclosporineNovartis Pharmaceuticals CorporationNDACurrent
0078-0241SandimmunecyclosporineNovartis Pharmaceuticals CorporationNDACurrent
0078-0241SandimmunecyclosporineNovartis Pharmaceuticals CorporationNDACurrent
0078-0241SandimmunecyclosporineNovartis Pharmaceuticals CorporationNDACurrent
0078-0241SandimmunecyclosporineNovartis Pharmaceuticals CorporationNDACurrent
0078-0241SandimmunecyclosporineNovartis Pharmaceuticals CorporationNDACurrent

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
85537SUPPL 2026-03-26
85299SUPPL 2026-03-09
75628SUPPL 2023-09-29
75608SUPPL 2023-09-29
70797SUPPL2022-04-20
70763SUPPL2022-04-14
30187SUPPL2015-04-02
17947SUPPL2015-04-01
39049SUPPL2013-05-09
30186SUPPL2013-05-07
7898SUPPL2012-09-05
17946SUPPL2012-08-31
17945SUPPL2010-05-07
30185SUPPL2010-05-06
30184SUPPL2009-11-10
17944SUPPL2009-10-14
30183SUPPL2006-03-23
17943SUPPL2006-03-10
17942SUPPL2005-07-26
7897SUPPL2005-07-26
30182SUPPL2004-06-17
7896SUPPL2004-06-17
7895SUPPL2004-06-17
39048SUPPL2004-03-03
17941SUPPL2004-03-03
30181SUPPL2004-02-27
39047SUPPL2003-03-05
17940SUPPL2003-03-05